OptimizeRx Announces Departure of CEO William Febbo and Appointment of Stephen Silvestro as Interim CEO

Company Leadership Transition - William J. Febbo, CEO of OptimizeRx, will depart the company effective December 31, 2024, to pursue other opportunities, while providing advisory services until March 31, 2025 [9] - Stephen Silvestro has been appointed as the interim CEO during the search for a new candidate, having previously served as Chief Commercial Officer and President [10] Company Growth and Strategy - OptimizeRx has experienced significant growth under Febbo's leadership, transforming from a single point of care product to an omnichannel platform, and is well-positioned for future growth [1] - The company reaffirms its financial guidance for the full year 2024, expecting to achieve results at the higher end of its revenue and adjusted EBITDA guidance range [2] Company Overview - OptimizeRx provides healthcare technology solutions that facilitate engagement between life sciences organizations, healthcare providers, and patients, connecting over 2 million U.S. healthcare providers through its digital point-of-care network [6]